Free Trial

Abingdon Health (ABDX) Competitors

Abingdon Health logo
GBX 5.88 -0.12 (-2.00%)
As of 05/1/2025 11:33 AM Eastern

ABDX vs. AGL, YGEN, PRM, GDR, VRCI, GENI, DMTR, LLAI, LLA, and IDHC

Should you be buying Abingdon Health stock or one of its competitors? The main competitors of Abingdon Health include ANGLE (AGL), Yourgene Health (YGEN), Proteome Sciences (PRM), genedrive (GDR), Verici Dx (VRCI), GENinCode (GENI), Deepmatter Group (DMTR), LungLife AI (LLAI), LLA.L,0P0001T9GN,0 (LLA), and Integrated Diagnostics (IDHC). These companies are all part of the "diagnostics & research" industry.

Abingdon Health vs.

Abingdon Health (LON:ABDX) and ANGLE (LON:AGL) are both small-cap medical companies, but which is the better stock? We will contrast the two companies based on the strength of their valuation, risk, earnings, institutional ownership, media sentiment, profitability, community ranking, dividends and analyst recommendations.

In the previous week, Abingdon Health's average media sentiment score of 1.02 beat ANGLE's score of 0.00 indicating that Abingdon Health is being referred to more favorably in the media.

Company Overall Sentiment
Abingdon Health Positive
ANGLE Neutral

33.5% of Abingdon Health shares are held by institutional investors. Comparatively, 18.8% of ANGLE shares are held by institutional investors. 48.9% of Abingdon Health shares are held by company insiders. Comparatively, 16.2% of ANGLE shares are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock will outperform the market over the long term.

ANGLE has a consensus price target of GBX 40, indicating a potential upside of 362.43%. Given ANGLE's stronger consensus rating and higher probable upside, analysts plainly believe ANGLE is more favorable than Abingdon Health.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Abingdon Health
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
0.00
ANGLE
0 Sell rating(s)
0 Hold rating(s)
1 Buy rating(s)
0 Strong Buy rating(s)
3.00

Abingdon Health has a net margin of -20.72% compared to ANGLE's net margin of -890.91%. Abingdon Health's return on equity of -62.56% beat ANGLE's return on equity.

Company Net Margins Return on Equity Return on Assets
Abingdon Health-20.72% -62.56% -17.93%
ANGLE -890.91%-76.01%-29.89%

ANGLE received 183 more outperform votes than Abingdon Health when rated by MarketBeat users.

CompanyUnderperformOutperform
Abingdon HealthN/AN/A
ANGLEOutperform Votes
183
62.46%
Underperform Votes
110
37.54%

Abingdon Health has a beta of 0.13, meaning that its stock price is 87% less volatile than the S&P 500. Comparatively, ANGLE has a beta of 0.22, meaning that its stock price is 78% less volatile than the S&P 500.

Abingdon Health has higher revenue and earnings than ANGLE. Abingdon Health is trading at a lower price-to-earnings ratio than ANGLE, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Abingdon Health£3.84M2.96-£796.37K-£0.41-14.30
ANGLE£2.44M11.41-£21.76M-£6.76-1.28

Summary

Abingdon Health beats ANGLE on 9 of the 16 factors compared between the two stocks.

Get Abingdon Health News Delivered to You Automatically

Sign up to receive the latest news and ratings for ABDX and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

ABDX vs. The Competition

MetricAbingdon HealthDiagnostics & Research IndustryMedical SectorLON Exchange
Market Cap£11.39M£729.90M£5.47B£2.56B
Dividend YieldN/A5.44%5.11%4.97%
P/E Ratio-14.301.8522.51132.50
Price / Sales2.96447.32397.62227,865.53
Price / Cash2.2511.4238.1828.11
Price / Book8.082.686.734.54
Net Income-£796,369.64£308.37B£3.22B£5.84B
7 Day Performance-2.00%-1.66%1.58%3.31%
1 Month Performance-6.37%-2.98%4.05%9.43%
1 Year Performance-43.95%-8.38%15.75%114.47%

Abingdon Health Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
ABDX
Abingdon Health
N/AGBX 5.88
-2.0%
N/A-43.9%£11.39M£3.84M-14.3084Positive News
Gap Up
AGL
ANGLE
1.6414 of 5 stars
GBX 8.75
-2.8%
GBX 40
+357.1%
-38.2%£28.20M£2.44M-1.29650Gap Down
YGEN
Yourgene Health
N/AN/AN/AN/A£16.43M£29.67M-51.50253
PRM
Proteome Sciences
N/AGBX 3
-4.8%
N/A-21.9%£8.86M£10.88B-2.17240Gap Down
GDR
genedrive
N/AGBX 1.51
-0.3%
N/A-67.6%£8.55M£1.50M-0.4243
VRCI
Verici Dx
N/AGBX 1.80
-4.0%
N/A-80.0%£5.46M£5.91M-1.0419Gap Down
GENI
GENinCode
N/AGBX 2.42
-1.4%
N/A-78.6%£4.28M£2.67M-0.702,300
DMTR
Deepmatter Group
N/AN/AN/AN/A£1.33M£1.04M-0.11N/AGap Down
LLAI
LungLife AI
N/AGBX 2.08
-7.8%
N/A-89.1%£688,000.00£33,871.03-0.1615Gap Down
LLA
LLA.L,0P0001T9GN,0
N/AN/AN/AN/A£0.00N/A-8.3315Gap Down
High Trading Volume
IDHC
Integrated Diagnostics
N/AGBX 0.36
+2.6%
N/A+3.8%£10.60B£23.29T13.386,692Gap Up

Related Companies and Tools


This page (LON:ABDX) was last updated on 5/2/2025 by MarketBeat.com Staff
From Our Partners